Anti-cancer effect of naringin in human lung carcinoma cell line

Authors

  • Purushothaman Ayyakkannu Department of Biochemistry and Microbiology, PERI College of Arts and Science (Affiliated to University of Madras), PERI Knowledge Park, Chennai 600048, Tamil Nadu, India.
  • Showket Yahyah Department of Biochemistry, Mohamed Sathak College of Arts and Science (Affiliated to University of Madras), Chennai 600119, Tamil Nadu, India.
  • Meenatchi Packirisamy Department of Biochemistry, Mohamed Sathak College of Arts and Science (Affiliated to University of Madras), Chennai 600119, Tamil Nadu, India. https://orcid.org/0000-0003-2540-9008
  • Subramanian Rajasekaran Paranthaman Department of Biochemistry and Microbiology, PERI College of Arts and Science (Affiliated to University of Madras), PERI Knowledge Park, Chennai 600048, Tamil Nadu, India. https://orcid.org/0000-0001-6120-3758

DOI:

https://doi.org/10.3329/bjp.v18i3.46647

Keywords:

Anti-cancer, Cell line A549, DNA fragmentation Assay, MTT Assay

Abstract

No abstract

Downloads

Download data is not yet available.
Abstract
18
Download
16

References

Bao R, Chan P. Novel compounds in the treatment of lung cancer: Current and developing therapeutic agents. J Exp Pharmacol. 2011: 16: 21-34.

Hanahan D and Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-74.

Rauf A, Shariati MA, Imran M, Bashir K, Khan SA, Mitra S, Emran TB, Badalova K, Uddin MS, Mubarak MS, Aljohani ASM, Alhumaydhi FA, Derkho M, Korpayev S, Zengin G. Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent. Environ Sci Pollut Res Int. 2022; 29: 31025-41.

Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem. 2000; 275: 9390-95.

Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, et al. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. Natl Cancer Inst. 1990; 82: 111-16.

Downloads

Published

2023-08-21

How to Cite

Ayyakkannu, P., S. . Yahyah, M. . Packirisamy, and S. R. Paranthaman. “Anti-Cancer Effect of Naringin in Human Lung Carcinoma Cell Line”. Bangladesh Journal of Pharmacology, vol. 18, no. 3, Aug. 2023, pp. 113-5, doi:10.3329/bjp.v18i3.46647.

Issue

Vol. 18 No. 3 (2023)

Section

Letter to the Editor

License

Copyright (c) 2023 Purushothaman Ayyakkannu, Showket Yahyah, Meenatchi Packirisamy, Subramanian Rajasekaran Paranthaman

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).